- Jordan : 0096264600444 - 00962778455550 - 00962781409934 - 00962790633919
- UAE : 00971600560003
The world's biggest scientific documented health website for the happiness and health of your family, with science and faith we build the balance
77300171
Potent anti-obesity effect of enteric-coated lactoferrin: decrease in visceral fat accumulation in Japanese men and women with abdominal obesity after 8-week .
| No. | Divisions/Titles for Abstract | Details | ||
| 1 | Abstract Title | Potent anti-obesity effect of enteric-coated lactoferrin: decrease in visceral fat accumulation in Japanese men and women with abdominal obesity after 8-week administration of enteric-coated lactoferrin tablets. | ||
| 2 | Abstract Source | Br J Nutr, 104, 1688-95. | ||
| 3 | Abstract Author(s) | Ono, T., Murakoshi, M., Suzuki, N., Iida, N., Ohdera, M., Iigo, M., Yoshida, T., Sugiyama, K. & Nishino, H. | ||
| 4 | Article Affiliation | Research and Development Headquarters, Lion Corporation, Odawara, Kanagawa, Japan. tomoono@lion.co.jp. | ||
| 5 | Abstract | Lactoferrin (LF), a multifunctional glycoprotein in mammalian milk, is reported to exert a modulatory effect on lipid metabolism. The aim of the present study was to elucidate whether enteric-coated LF (eLF) might improve visceral fat-type obesity, an underlying cause of the metabolic syndrome. Using a double-blind, placebo-controlled design, Japanese men and women (n 26; aged 22-60 years) with abdominal obesity (BMI>25 kg/m2, and visceral fat area (VFA)>100 cm2) consumed eLF (300 mg/d as bovine LF) or placebo tablets for 8 weeks. Measurement of the total fat area, VFA and subcutaneous fat area from computed tomography images revealed a significant reduction in VFA ( - 14.6 cm2) in the eLF group, as compared with the placebo controls ( - 1.8 cm2; P = 0.009 by ANCOVA). Decreases in body weight, BMI and hip circumference in the eLF group ( - 1.5 kg, - 0.6 kg/m2, - 2.6 cm) were also found to be significantly greater than with the placebo (+1.0 kg, +0.3 kg/m2, - 0.2 cm; P = 0.032, 0.013, 0.041, respectively). There was also a tendency for a reduction in waist circumference in the eLF group ( - 4.4 cm) as compared with the placebo group ( - 0.9 cm; P = 0.073). No adverse effects of the eLF treatment were found with regard to blood lipid or biochemical parameters. From these results, eLF appears to be a promising agent for the control of visceral fat accumulation. | ||
| 6 | Summary | - | ||
| 7 | Article Published Date | 2010. | ||
| 8 | Study Type | A double-blind, placebo-controlled design. | ||
| 9 | Substances | Colostrum. | ||
| 10 | Diseases | Obesity. | ||
| 11 | Pharmacological Actions | Treatment of Obesity. | ||
| 12 | Link | https://goo.gl/6UPS56 | ||
Add comment
Hottest Articles
- Polyphenolic profile, antioxidant properties and antimicrobial activity of grape skin extracts of 14 Vitis vinifera varieties grown in Dalmatia (Croatia).
- Evaluation of antimicrobial activity in olive (olea europaea) leaf extract.
- Resveratrol exerts anti-obesity effects via mechanisms involving down-regulation of adipogenic and inflammatory processes in mice.
- Reduced Serum Level of Transforming Growth Factor-β in Patients with IgA Deficiency.
Contact us
Phone number : 0096264600444 - 00962778455550 - 00962781409934 - 00962790633919
UAE Branch : UAE Sharjah, al sharq street
Phone number : 00971600560003
All right reserved to Dr.jameel alqudsi dweik © 2018 | Privacy Policy | Terms of service | Refund Policy
Made with by Tashfier
Comments